MetLife
Market Cap
US$45.1b
Last Updated
2021/01/27 23:31 UTC
Data Sources
Company Financials +
Executive Summary
MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses worldwide. More Details
Rewards
Risk Analysis
Earnings are forecast to decline by an average of 7.1% per year for the next 3 years
Snowflake Analysis
Undervalued established dividend payer.
Similar Companies
Share Price & News
How has MetLife's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MET is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: MET's weekly volatility (5%) has been stable over the past year.
Market Performance
7 Day Return
-6.3%
MET
-5.6%
US Insurance
-2.7%
US Market
1 Year Return
-4.1%
MET
-8.1%
US Insurance
21.2%
US Market
Return vs Industry: MET exceeded the US Insurance industry which returned -5.2% over the past year.
Return vs Market: MET underperformed the US Market which returned 24.3% over the past year.
Shareholder returns
| MET | Industry | Market | |
|---|---|---|---|
| 7 Day | -6.3% | -5.6% | -2.7% |
| 30 Day | 4.7% | -1.9% | 1.8% |
| 90 Day | 29.8% | 14.2% | 16.4% |
| 1 Year | 0.5%-4.1% | -5.4%-8.1% | 23.9%21.2% |
| 3 Year | 13.7%0.7% | 7.5%-0.6% | 43.7%34.2% |
| 5 Year | 54.1%15.4% | 66.0%45.1% | 124.3%99.2% |
Long-Term Price Volatility Vs. Market
How volatile is MetLife's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall St
MetLife (NYSE:MET) Has Compensated Shareholders With A Respectable 58% Return On Their Investment3 weeks ago | Simply Wall St
Why MetLife, Inc. (NYSE:MET) Is A Dividend Rockstar1 month ago | Simply Wall St
Did MetLife, Inc. (NYSE:MET) Insiders Sell Shares?Valuation
Is MetLife undervalued compared to its fair value and its price relative to the market?
27.1%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: MET ($48.41) is trading below our estimate of fair value ($66.45)
Significantly Below Fair Value: MET is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: MET is good value based on its PE Ratio (7.9x) compared to the US Insurance industry average (14.4x).
PE vs Market: MET is good value based on its PE Ratio (7.9x) compared to the US market (21.2x).
Price to Earnings Growth Ratio
PEG Ratio: MET's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: MET is good value based on its PB Ratio (0.6x) compared to the US Insurance industry average (1x).
Next Steps
Future Growth
How is MetLife forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
-7.1%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MET's earnings are forecast to decline over the next 3 years (-7.1% per year).
Earnings vs Market: MET's earnings are forecast to decline over the next 3 years (-7.1% per year).
High Growth Earnings: MET's earnings are forecast to decline over the next 3 years.
Revenue vs Market: MET's revenue (3.5% per year) is forecast to grow slower than the US market (10.6% per year).
High Growth Revenue: MET's revenue (3.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MET's Return on Equity is forecast to be low in 3 years time (9.7%).
Next Steps
Past Performance
How has MetLife performed over the past 5 years?
11.5%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MET has high quality earnings.
Growing Profit Margin: MET's current net profit margins (8.5%) are lower than last year (10.5%).
Past Earnings Growth Analysis
Earnings Trend: MET's earnings have grown by 11.5% per year over the past 5 years.
Accelerating Growth: MET's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: MET had negative earnings growth (-22%) over the past year, making it difficult to compare to the Insurance industry average (5.9%).
Return on Equity
High ROE: MET's Return on Equity (7.9%) is considered low.
Next Steps
Financial Health
How is MetLife's financial position?
Financial Position Analysis
Short Term Liabilities: MET's short term assets ($68.7B) exceed its short term liabilities ($67.6B).
Long Term Liabilities: MET's short term assets ($68.7B) do not cover its long term liabilities ($639.3B).
Debt to Equity History and Analysis
Debt Level: MET's debt to equity ratio (150.2%) is considered high.
Reducing Debt: MET's debt to equity ratio has increased from 92.8% to 150.2% over the past 5 years.
Debt Coverage: MET's debt is not well covered by operating cash flow (10.6%).
Interest Coverage: MET's interest payments on its debt are well covered by EBIT (8.5x coverage).
Balance Sheet
Next Steps
Dividend
What is MetLife current dividend yield, its reliability and sustainability?
3.80%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: MET's dividend (3.8%) is higher than the bottom 25% of dividend payers in the US market (1.39%).
High Dividend: MET's dividend (3.8%) is low compared to the top 25% of dividend payers in the US market (3.87%).
Stability and Growth of Payments
Stable Dividend: MET's dividends per share have been stable in the past 10 years.
Growing Dividend: MET's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (29.3%), MET's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: MET's dividends in 3 years are forecast to be well covered by earnings (37.2% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.8yrs
Average management tenure
CEO
Michel Khalaf (56 yo)
1.67yrs
Tenure
US$14,570,581
Compensation
Mr. Michel A. Khalaf is a Director at The Geneva Association since June 10, 2020. He has been the President, Chief Executive Officer and Director of MetLife, Inc. since May 1, 2019. Mr. Khalaf served as Pr...
CEO Compensation Analysis
Compensation vs Market: Michel's total compensation ($USD14.57M) is above average for companies of similar size in the US market ($USD10.56M).
Compensation vs Earnings: Michel's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.67yrs | US$14.57m | 0.0035% $ 1.6m | |
| Executive VP & CFO | 2.67yrs | US$6.32m | 0.0034% $ 1.5m | |
| Executive VP and Head of Global Technology & Operations | 1.17yrs | US$4.69m | 0.0010% $ 469.0k | |
| Executive VP & Chief Investment Officer | 9.67yrs | US$7.09m | 0.015% $ 6.7m | |
| Executive VP & President of U.S. Business | 3.33yrs | US$4.51m | 0.0020% $ 915.5k | |
| Executive VP & Chief Accounting Officer | 1.83yrs | no data | no data | |
| Executive VP & Chief Information Officer | 0.17yr | no data | no data | |
| Senior VP & Head of Investor Relations | no data | no data | no data | |
| Executive VP & General Counsel | 3.5yrs | no data | 0.00078% $ 351.8k | |
| Chief Communications Officer | 2.75yrs | no data | no data | |
| Executive VP & Global Chief Marketing Officer | 6yrs | no data | 0.0048% $ 2.2m | |
| Executive VP & Chief HR Officer | 3.5yrs | no data | 0.0019% $ 843.3k |
2.8yrs
Average Tenure
50yo
Average Age
Experienced Management: MET's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.67yrs | US$14.57m | 0.0035% $ 1.6m | |
| Executive VP | no data | no data | no data | |
| Independent Director | 7.33yrs | US$326.75k | 0% $ 0 | |
| Independent Director | 4.25yrs | US$341.75k | 0.0017% $ 771.1k | |
| Independent Director | 2.92yrs | US$301.75k | 0.0013% $ 572.7k | |
| Independent Director | 7.83yrs | US$301.75k | 0.0035% $ 1.6m | |
| Independent Director | 5.92yrs | US$336.75k | 0.0025% $ 1.1m | |
| Independent Director | 11.75yrs | US$306.75k | 0.0055% $ 2.5m | |
| Independent Director | 6.92yrs | US$302.23k | 0.0024% $ 1.1m | |
| Independent Chairman | 1.67yrs | US$520.24k | 0.00086% $ 387.8k | |
| Independent Director | 2.17yrs | US$301.75k | 0.0010% $ 451.0k | |
| Independent Director | 16.92yrs | US$326.85k | 0.00052% $ 234.5k |
5.9yrs
Average Tenure
66yo
Average Age
Experienced Board: MET's board of directors are considered experienced (5.9 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
MetLife, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: MetLife, Inc.
- Ticker: MET
- Exchange: NYSE
- Founded: 1863
- Industry: Life and Health Insurance
- Sector: Insurance
- Market Cap: US$45.096b
- Shares outstanding: 899.95m
- Website: https://www.metlife.com
Number of Employees
Location
- MetLife, Inc.
- 200 Park Avenue
- New York
- New York
- 10166-0188
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| MET | NYSE (New York Stock Exchange) | Yes | Common Stock | US | USD | Apr 2000 |
| MWZ | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Apr 2000 |
| MWZ | XTRA (XETRA Trading Platform) | Yes | Common Stock | DE | EUR | Apr 2000 |
| MET * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Apr 2000 |
| 0K0X | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Apr 2000 |
| METL | WBAG (Wiener Boerse AG) | Yes | Common Stock | AT | EUR | Apr 2000 |
| MET.PRA | NYSE (New York Stock Exchange) | PFD A FLT RATE | US | USD | Jun 2005 | |
| METB34 | BOVESPA (Bolsa de Valores de Sao Paulo) | EACH BDR REPR 1 COM STK USD0.01 | BR | BRL | Aug 2015 | |
| A19YH3 | DB (Deutsche Boerse AG) | PERP JR SB GLBL | DE | USD | Mar 2018 | |
| MET.PRE | NYSE (New York Stock Exchange) | 5.625 NCUM PFD E | US | USD | May 2018 | |
| MET.PRF | NYSE (New York Stock Exchange) | 4.75% DP PFD F | US | USD | Jan 2020 |
Biography
MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Af...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/27 23:31 |
| End of Day Share Price | 2021/01/27 00:00 |
| Earnings | 2020/09/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.